Matrix metalloproteinase-3 (MMP-3) in synovial fluid with temporomandibular joint disorders

Matrix metalloproteinase-3 {MMP-3, stromelysin) is known to degrade certain matrix components, including proteoglycans, fibronectin, laminin and collagens. We lnvestigated the early signs ot cartilage degradation by assaying MMP-3 in the synoviat fluid of human temporomandibular jojnts with internal derangement (ID) or osteoarthritis (OA). Synovial fluid was collected from the upper joint space by direct aspiration {nondiluted synovial fluid) or by pumping with lidocaine (diluted synovial tluid). MMP-3 was visualized by casein enzymography and measured by one-step sandwich enzyme immunoassay using an anti-human MMP-3 antibody that recegnizes both active enzyme and inactive proenzyme. The concentration of MMP-3 with ID in both diluted and non-diluted synevial fluid was signiticantly greater than that with OA or in the asymptomatic controls (p<O.OOI). Enzymatically active components were detected in the non-diluted synovial tluid, but not in the diluted synovial fluid. Active MMP-3 was detected only in the nondiluted synovial fluid with OA, while inactive MMP-3 was observed in the non-dituted synovial fluid both with ID and with OA. These resutts indicate that MMP-3 may be released as preenzyme into the synovial ftuid uring the early stages ot degenerative changes in the TMJ. Subsequently, progressive TMJ destruction may induce the release of active MMP-3. We concluded that MMP-3 assay using synovial fluid may be a useful marker ter the diagnosis of TMJ disorders. (J Osaka Dent Univ 2003 ; 37 : 123-127.}

[1]  S. Fujita,et al.  The localization of matrix metalloproteinase-3 and tenascin in synovial membrane of the temporomandibular joint with internal derangement. , 2008, Oral diseases.

[2]  Michael F. G. Schmidt,et al.  Synovial MMP-3 and TIMP-1 levels and their correlation with cytokine expression in canine rheumatoid arthritis. , 2003, Veterinary immunology and immunopathology.

[3]  L. Brunnberg,et al.  Biomarkers of joint tissue metabolism in canine osteoarthritic and arthritic joint disorders. , 2002, Osteoarthritis and cartilage.

[4]  V. Pistoia,et al.  Serum and synovial fluid concentrations of matrix metalloproteinases 3 and its tissue inhibitor 1 in juvenile idiopathic arthritides. , 2002, The Journal of rheumatology.

[5]  A. Poole,et al.  Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis. , 2001, Arthritis and rheumatism.

[6]  D. Woolley,et al.  Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. , 2001, Arthritis and rheumatism.

[7]  M. Malaise,et al.  Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not. , 2000, Rheumatology.

[8]  P. R. Weeren,et al.  Influence of development and joint pathology on stromelysin enzyme activity in equine synovial fluid , 2000, Annals of the rheumatic diseases.

[9]  Y. Mikuni‐Takagaki,et al.  Identification of matrix metalloproteinases (MMPs) in synovial fluid from patients with temporomandibular disorder. , 1998, European journal of oral sciences.

[10]  R. Moskowitz,et al.  Increased secretion and activity of matrix metalloproteinase-3 in synovial tissues and chondrocytes from experimental osteoarthritis. , 1998, Osteoarthritis and cartilage.

[11]  E. Kubota,et al.  Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. , 1998, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[12]  S. Kopp,et al.  Interleukin-1beta in plasma and synovial fluid in relation to radiographic changes in arthritic temporomandibular joints. , 1998, European journal of oral sciences.

[13]  K. Kakudo,et al.  Chondroitin sulfate isomers in synovial fluid of healthy and diseased human temporomandibular joints. , 1997, European journal of oral sciences.

[14]  B. Henderson,et al.  The role of oxygen free radicals in idiopathic facial pain. , 1997, The British journal of oral & maxillofacial surgery.

[15]  G. Murphy,et al.  Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? , 1997, Matrix biology : journal of the International Society for Matrix Biology.

[16]  D. Hamblen,et al.  Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. , 1995, Annals of the rheumatic diseases.

[17]  D. Taylor,et al.  Increased serum proMMP-3 in inflammatory arthritides: a potential indicator of synovial inflammatory monokine activity. , 1994, Annals of the rheumatic diseases.

[18]  P. Roughley,et al.  Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage. , 1993, Matrix.

[19]  Y. Okada,et al.  A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[20]  H. Roos,et al.  Cartilage matrix metabolism in osteoarthritis: markers in synovial fluid, serum, and urine. , 1992, Clinical biochemistry.

[21]  A. Kang,et al.  The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. , 1990, Arthritis and rheumatism.

[22]  J. Pelletier,et al.  The role of cytokines in osteoarthritis pathophysiology. , 2002, Biorheology.

[23]  A. Nagano,et al.  Levels of Rheumatoid Factor Isotypes, Metalloproteinase-3 and Tissue Inhibitor of Metalloproteinase-1 in Synovial Fluid from Various Arthritides , 2000, Clinical Rheumatology.

[24]  A. Roessner,et al.  Immunohistochemical analysis of several proteolytic enzymes as parameters of cartilage degradation. , 1998, Pathology, research and practice.